Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982578priorityCriticalpatent/ECSP982578A/en
Publication of ECSP982578ApublicationCriticalpatent/ECSP982578A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención proporciona una composición farmacéutica acuosa que comprende de 5 a 200 mg/ml de eltriptán hemisulfato y del 0,5 a 2,0% en peso/volumen de cafeina.The present invention provides an aqueous pharmaceutical composition comprising 5 to 200 mg / ml eltriptan hemisulfate and 0.5 to 2.0% w / v caffeine.
DERIVATIVES OF PIRROLIDIN - 2, 3, 4- TRION -3- OXIME SUBSTITUTED PROCEDURES FOR ITS PREPARATION, MEDICINES CONTAINING THESE COMPOUNDS AND THE USE OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES